Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Advaxis Inc.

Start price
Target price
Perf. (%)
€0.059
04.02.24
-
04.02.25
-
23.09.22

StockNews.com 
04.02.24 50%
buy
Amedisys Inc.

Start price
Target price
Perf. (%)
€86.50
04.02.24
-
04.02.25
0.58%
30.08.24

StockNews.com 
04.02.24 50%
sell
Bellicum Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.071
04.02.24
-
04.02.25
-9.93%
05.03.24

StockNews.com 
04.02.24 50%
sell
Cyclacel Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€0.22
04.02.24
-
04.02.25
-
15.12.23

StockNews.com 
04.02.24 50%
sell
Genocea Biosciences Inc.

Start price
Target price
Perf. (%)
€0.009
04.02.24
-
04.02.25
-
23.12.22

StockNews.com 
04.02.24 50%
buy
Natural Alternat.

Start price
Target price
Perf. (%)
€5.60
04.02.24
-
04.02.25
-14.64%
30.08.24

StockNews.com 
04.02.24 50%
sell
Neptune Wellness Solutions Inc

Start price
Target price
Perf. (%)
€0.14
04.02.24
-
04.02.25
-
08.09.23

StockNews.com 
04.02.24 50%
sell
InVivo Therapeutics Holdings

Start price
Target price
Perf. (%)
€0.30
04.02.24
-
04.02.25
59.77%
19.07.24

StockNews.com 
04.02.24 50%
buy
Pro-Dex Inc.

Start price
Target price
Perf. (%)
€19.00
04.02.24
-
04.02.25
7.37%
30.08.24

StockNews.com 
04.02.24 50%
buy
Trinity Biotech ADR

Start price
Target price
Perf. (%)
€0.61
04.02.24
-
04.02.25
-32.46%
22.02.24

StockNews.com 
04.02.24 50%
buy
MacroGenics Inc.

Start price
Target price
Perf. (%)
€14.40
04.02.24
€20.00
30.11.25
-77.89%
13.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Larimar Therapeutics Inc.

Start price
Target price
Perf. (%)
€6.00
04.02.24
€7.00
31.03.26
21.67%
30.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 70%
buy
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€0.98
04.02.24
€1.50
31.10.25
14.29%
29.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Carbylan Therapeutics Inc

Start price
Target price
Perf. (%)
€14.10
04.02.24
€22.00
31.03.26
-14.18%
30.08.24

Could be very worthwhile Investment >20% year
BiotechBee 
04.02.24 60%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.00
03.02.24
-
03.02.25
-6.99%
17:21

StockNews.com 
03.02.24 50%
sell
Omeros Corp.

Start price
Target price
Perf. (%)
€3.03
03.02.24
-
03.02.25
23.75%
30.08.24

StockNews.com 
03.02.24 50%
sell
Novan Inc

Start price
Target price
Perf. (%)
€0.001
03.02.24
-
03.02.25
-
19.09.23

StockNews.com 
03.02.24 50%
buy
Bio-Gate AG

Start price
Target price
Perf. (%)
€1.05
03.02.24
-
03.02.25
1.90%
17.02.24

Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Taurito 
03.02.24 0%
buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€45.67
02.02.24
-
-
03.02.24

Could be worthwhile Investment >10% per year
blaugold 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.20
02.02.24
€128.74
02.02.25
-7.15%
17:21

Truist Financial Co. 
02.02.24 50%
buy
Merck & Co. Inc.

Start price
Target price
Perf. (%)
€117.60
02.02.24
€137.06
02.02.25
-7.46%
17:21

UBS Group AG 
02.02.24 50%
buy
Ensign Group Inc.

Start price
Target price
Perf. (%)
€112.00
02.02.24
€120.45
02.02.25
23.31%
09:30

Oppenheimer Holdings Inc. 
02.02.24 50%
buy
Hologic Inc.

Start price
Target price
Perf. (%)
€67.16
02.02.24
-
02.02.25
9.44%
15:39

William Blair 
02.02.24 50%
buy
Bio-Techne Corp.

Start price
Target price
Perf. (%)
€61.50
02.02.24
€80.65
02.02.25
10.11%
29.08.24

Stephens 
02.02.24 50%
sell
Align Technology

Start price
Target price
Perf. (%)
€254.40
02.02.24
€208.24
02.02.25
-15.92%
15:48

The Goldman Sachs Group, Inc. 
02.02.24 50%